http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104017746-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-225 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate | 2014-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104017746-B |
| titleOfInvention | Lactobacillus, its composition and the application for preparing heart and hepatic disease caused by treatment erythematosus lupus |
| abstract | A kind of purposes the present invention relates to lactobacillus, its composition and for treating heart caused by erythematosus lupus and hepatic disease, the separation strains of a following at least strains of the composition comprising effective dose：Lactobacillus paracasei GMNL 32, lactobacillus reuteri GMNL 89 or lactobacillus reuteri GMNL 263, and pharmaceutically acceptable supporting agent.Heart caused by erythematosus lupus and hepatic disease can be treated by above-mentioned lactobacillus and/or the composition containing it. |
| priorityDate | 2014-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 289.